$MIBE
Miami Breeze Car Care Inc

2023 Q4 Form 10-K Financial Statement

#000152013824000172 Filed on April 15, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $16.85K
YoY Change 35.46%
Cost Of Revenue $7.121K
YoY Change 17.14%
Gross Profit $9.729K
YoY Change 52.97%
Gross Profit Margin 57.74%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $857.0K
YoY Change -46.62%
Operating Profit -$847.3K
YoY Change -47.01%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.625K
YoY Change 1788.02%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$850.9K
YoY Change -46.79%
Net Earnings / Revenue -5049.92%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 33.47M shares
Diluted Shares Outstanding 33.47M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $74.89K $462.7K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $103.9K $170.6K
Prepaid Expenses $21.03K $411.8K
Receivables
Other Receivables
Total Short-Term Assets $199.8K $1.045M
YoY Change -80.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $199.8K $1.045M
Total Long-Term Assets $0.00 $0.00
Total Assets $199.8K $1.045M
YoY Change -80.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $630.00
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.81K $18.27K
YoY Change 30.32%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $23.81K $18.27K
Total Long-Term Liabilities
Total Liabilities $23.81K $18.27K
YoY Change 30.32%
SHAREHOLDERS EQUITY
Retained Earnings -$3.431M -$2.580M
YoY Change 32.98%
Common Stock $3.347K $3.347K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $176.0K $1.027M
YoY Change
Total Liabilities & Shareholders Equity $199.8K $1.045M
YoY Change -80.88%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$850.9K
YoY Change -46.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$387.8K
YoY Change -24.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$387.8K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$387.8K
YoY Change 86.98%
FREE CASH FLOW
Cash From Operating Activities -$387.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
363426 usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001872066
CY2022Q4 CIK0001872066 Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 CIK0001872066 Writeoff Of Obsolete Inventory Included In Operating Expenses
WriteoffOfObsoleteInventoryIncludedInOperatingExpenses
usd
CY2022 CIK0001872066 Increase Decrease In Prepaid Expenses Related Party
IncreaseDecreaseInPrepaidExpensesRelatedParty
usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Stock Issued1
StockIssued1
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33606966 shares
CY2023 dei Auditor Firm
AuditorFirmId
3223
CY2023 dei Auditor Name
AuditorName
Mercurius & Associates LLP
CY2023 dei Auditor Location
AuditorLocation
New Delhi, India
CY2023Q4 us-gaap Cash
Cash
74889 usd
CY2022Q4 us-gaap Cash
Cash
462729 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
103933 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
170642 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
155 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
411848 usd
CY2023Q4 CIK0001872066 Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
20870 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
199847 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1045219 usd
CY2022Q4 us-gaap Assets
Assets
1045219 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
17639 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
630 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18269 usd
CY2022Q4 us-gaap Liabilities
Liabilities
18269 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2022Q4 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33471966 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33471966 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33471966 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33471966 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3347 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3603676 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2580173 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1026950 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1045219 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
7121 usd
CY2023 us-gaap Gross Profit
GrossProfit
9729 usd
CY2022 us-gaap Gross Profit
GrossProfit
6360 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
56648 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
105333 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
64555 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
58247 usd
CY2023 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
363426 usd
CY2022 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
1011574 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
422435 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
1161172 usd
CY2023 CIK0001872066 Professional Fees Related Party
ProfessionalFeesRelatedParty
197000 usd
CY2022 CIK0001872066 Professional Fees Related Party
ProfessionalFeesRelatedParty
175025 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45879 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
105647 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
70499 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
-0 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
857016 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1605424 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-847287 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1599064 usd
CY2023 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
3625 usd
CY2022 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
192 usd
CY2023 us-gaap Other Expenses
OtherExpenses
3625 usd
CY2022 us-gaap Other Expenses
OtherExpenses
192 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-850912 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1599256 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33471966 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33471966 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33376998 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33376998 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2271698 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
50000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
304508 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1599256 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1026950 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-850912 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
176038 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-850912 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1599256 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
33333 usd
CY2022 CIK0001872066 Stockbased Professional Fees
StockbasedProfessionalFees
1011574 usd
CY2023 CIK0001872066 Writeoff Of Obsolete Inventory Included In Operating Expenses
WriteoffOfObsoleteInventoryIncludedInOperatingExpenses
70499 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3790 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
103904 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-48267 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-145139 usd
CY2023 CIK0001872066 Increase Decrease In Prepaid Expenses Related Party
IncreaseDecreaseInPrepaidExpensesRelatedParty
20870 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6170 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1188 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-630 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-387840 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-511926 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
304508 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
304508 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-387840 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-207418 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
462729 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
670147 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74889 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
462729 usd
CY2022 us-gaap Stock Issued1
StockIssued1
16667 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-850912 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3431085 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2580173 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-387840 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-511926 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
70499 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
103933 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
170642 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21025 usd
CY2023Q4 CIK0001872066 Prepaid Expenses Related Party
PrepaidExpensesRelatedParty
20870 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
411848 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
64555 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
58247 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
212000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2022Q4 CIK0001872066 Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
300000 shares
CY2022Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
300000 usd
CY2022Q2 us-gaap Share Price
SharePrice
1.00
CY2022Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1500 shares
CY2022Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4508 usd
CY2022Q2 us-gaap Share Price
SharePrice
3.00
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-178691 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-335844 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-42546 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-79963 usd
CY2023 CIK0001872066 Nondeductible Expenses
NondeductibleExpenses
94491 usd
CY2022 CIK0001872066 Nondeductible Expenses
NondeductibleExpenses
271676 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
126746 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
144131 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
350632 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
223886 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
350632 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
223886 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
350632 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
223886 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1348500 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
126746 usd

Files In Submission

Name View Source Status
0001520138-24-000172-index-headers.html Edgar Link pending
0001520138-24-000172-index.html Edgar Link pending
0001520138-24-000172.txt Edgar Link pending
0001520138-24-000172-xbrl.zip Edgar Link pending
cik0001872066-20231231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_01.jpg Edgar Link pending
image_02.jpg Edgar Link pending
image_03.jpg Edgar Link pending
image_04.jpg Edgar Link pending
image_05.jpg Edgar Link pending
image_06.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
miami-20241231_10k.htm Edgar Link pending
miami-20241231_10kex23z1.htm Edgar Link pending
miami-20241231_10kex31z1.htm Edgar Link pending
miami-20241231_10kex31z2.htm Edgar Link pending
miami-20241231_10kex32z2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
cik0001872066-20231231_lab.xml Edgar Link unprocessable
cik0001872066-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
miami-20241231_10k_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
cik0001872066-20231231_cal.xml Edgar Link unprocessable
cik0001872066-20231231_def.xml Edgar Link unprocessable